Full Length Research Paper
References
|
Calhoun David A, Glazer RD, Pettyjohn FP (2008). Efficacy and tolerability of combination therapy with valsartan hydrochlorothiazide in the initial treatment of severe hypertension. Curr. Med. Res. Opin. 24:2303-2311. Crossref |
||||
|
Gonzalez L, Lopez JA, Alonso RM (2002). Fast screening method for the determination of angiotensin II receptor antagonist in human plasma by high performance liquid chromatography with fluorimetric detection. J. Chromatogr A. 949:49-60. Crossref |
||||
|
Hao Li, Yingwu Wang, Yao Jiang, Yunbiao Tang, Jiang Wang, Limei Zhao, Jingkai Gu (2007). A liquid chromatography/tandem mass spectrometry method for the simultaneous quantification of valsartan and hydrochlorothiazide in human plasma. J. Chromatogr. B. 852: (1-2)436-442. Crossref |
||||
|
Hillaert S, Van den Bossche W (2003). Simultaneous determination of hydrochlorothiazide and several angiotensin –II-receptor antagonist by capillary electrophoresis. J. Pharm. Biomed. Anal. 31:329-339. Crossref |
||||
|
Iriarte G. Ferreirose N, Ibarrondo I, Alonso RM, Maguregui MI, Jimenez RM (2007). Biovalidation of an SPE-HPLC-UV-fluorescence method for the determination of valsartan and its metabolite valery-4-hydroxy-valsartan in human plasma. J. Sep. Sci. 30(14):2231-2240. Crossref |
||||
|
Ivanovic D, Malenovic A. Jancic B, Medenica M, Maskovic M (2007). Evaluation of impurities level of perindopril-butylamine in tablets. J. Pharm. Biomed. Anal. 44(5):1087-1094. Crossref |
||||
| Kadam BR, Bari SB (2007). Quantitative analysis of Valsartan and hydrochlorothiazide in tablets by high-performance thin layer chromatography with ultraviolet absorption densitometry. Acta Chromatogr.18:260-269. | ||||
|
Koseki N, Kawashita H, Hara H, Niina M, Tanaka M,Kawai R, Nagae Y, Masuda N(2007). Development and validation of a method for quantitative determination of valsartan in human plasma by liquid chromatography- tandem mass spectrometry. J. Pharm. Biomed. Anal. 43:1769-1774. Crossref |
||||
| Macek J, Klima J, Ptacek P (2006). Rapid determination of valsartan in human plasma by protein precipitation and high performance liquid chromatography. J. Chromatogr. 832(1):169-172. | ||||
| Medvedovici,. Mircioiu AC, David V (2000). Liquid extraction and HPLC-DAD assay of Hydrochlorothiazide from plasma for a bioequivalence study at the lowest therapeute dose. Eur. J. Drug Metab. Pharmacokinet. 25:91-96. | ||||
| Ramakrishna, Vishwottam NVS, Manoj KN, Koteshwara S, Wishu M, Varma S (2005). Sensitive liquid chromatography-tandem mass spectrometry method qualification of hydrochlorothiazide in human plasma. Biomed. Chromatogr. 19(10):751-760. | ||||
|
Sagirli O, Onal A, Toker SE, Sensoy D (2007). Simultaneous HPLC analysis of Olmesartan and Hydrochlorothiazide in combined tablets and in vitro dissolution studies. Chromatographia 66 (3-4):213-218. Crossref |
||||
|
Satana E, Altinay S, Goger Ng, Ozkan SA, Senturk Z (2001). Simultaneous determination of valsartan and hydrochlorothiazide in tablets by first derivative ultraviolet spectrophotometry and LC. J. Pharm. Biomed. Anal. 25:1009-13. Crossref |
||||
|
Sevgi Tatar, Serapsaglik (2002). Comparison of UV-and second derivative spectrophotometric and LC methods for the determination of valsartan in pharmaceutical formulation. J. Pharm. Biomed. Anal. 30(2):371-375. Crossref |
||||
|
Shah HJ, Kataria NB, Subbaiah G, Patel CN (2009). Simultaneous LC- MS- MS Analysis of Valsartan and Hydrochlorothiazide in Human Plasma. J. Chromatogr. 69(9-10):1055-1060. Crossref |
||||
|
Sioufi A, Marfil F, Godbillon J (1994). Automated determination of an angiotensin II receptor antagonist CGP 48933, in plasma by high performance liquid chromatography. J. Liq. Chromatogr. 17:2179-21 Crossref |
||||
| The European Pharmacopoeia (2009). 2009 Edition 6.6:5353-5354. EDQM, Council of Europe, Strasbourg, France: Verlag Publishers. | ||||
| The United States Pharmacopeia (2007). United States Pharmacopeial Convention Inc. 30th revision, Asian Edition, Twinbrook Parkway, Rochville MD. pp. 3447-3448. | ||||
| The United States Pharmacopeia (2008). United States Pharmacopeial Convention Inc. 30th revision, Asian Edition, Twinbrook Parkway, Rochville MD. pp 3497-3498. | ||||
| The United States Pharmacopeia (2009). United States Pharmacopeial Convention Inc. 30th revision, Asian Edition, Twinbrook Parkway, Rochville MD. pp 3843-3844. | ||||
|
Tian DF, Tian XL, T.Wang ZY, Mo FK (2008) Simultaneous determination of Valsartan and hydrochlorothiazide in tablets by RP- HPLC. Indian J. Pharm. Sci. 70:372-374. Crossref |
||||
| Vetuschi C, Giannandrea A, Carlucci, Mazzeo G, Farmaco P (2005). Determination of Hydrochlorothiazide and irbesartan in pharmaceuticals by fourth order UV derivative spectrophotometry. Analyt. Lett. 60(8):665-670. | ||||
|
Zendelovaska, Dragica, Stafilov, Trajce, Milosevski, Peter (2004). Development of solid phase extraction method and its application for determination of hydrochlorothiazide in hu-man plasma using HPLC. Biomed. Chromatogr. 18(2):71-76. Crossref |
||||
Copyright © 2025 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
